BichlienNguyenMD

Oncology • Fountain Valley, CA

Physician

Join to view full profile

Dr. Nguyen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Nguyen's full profile

Already have an account?

Office
9900 Talbert Ave
Ste 103A
Fountain Valley, CA 92708
Phone+1 714-378-5005

Fax+1 714-378-5611

Education & Training

University of California (Irvine)Fellowship, Hematology and Medical Oncology, 1990 - 1993
University of California (Irvine)Residency, Internal Medicine, 1987 - 1990
University of California, Irvine, School of MedicineClass of 1987

Certifications & Licensure

CA State Medical License 1988 - 2024

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
Active, not recruiting
Phase 3
Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab Start of enrollment: 2010 Mar 01
Completed
Phase 2
A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer Start of enrollment: 2010 Aug 13
Completed
Phase 3
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
Completed
A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer. Start of enrollment: 2013 Feb 26
Completed
Phase 2
Join now to see all

Publications & Presentations

PubMed

60 citations
Chemosensitivity Predicted by BluePrint 80-Gene Functional Subtype and MammaPrint in the Prospective Neoadjuvant Breast Registry Symphony Trial (NBRST)
P Whitworth, Lisette Stork-Sloots, Femke A. de Snoo, Paul Richards, Michael Rotkis
Annals of Surgical Oncology. 2014-08-07
22 citations
Photovoltaic-driven organic electrosynthesis and efforts toward more sustainable oxidation reactions
Bichlien H. Nguyen, Robert J. Perkins, Jake A. Smith, Kevin D. Moeller
Beilstein Journal of Organic Chemistry. 2015-02-23
35 citations
Synthetic DNA applications in information technology.
Linda C Meiser, Bichlien H Nguyen, Yuan-Jyue Chen, Jeff Nivala, Karin Strauss
Nature Communications. 2022-01-17

Professional Memberships

American Society of Clinical Oncology - ASCO
Member